Quote of the Day
"I’d say hybrid products that erase the boundary between active management and smart beta are where things are headed. Those are truly multi-factor, risk-aware investment strategies."(Nick Baturin)
Chart of the Day
The story of the only analyst who had a sell-rating on Valeant Pharmaceuticals ($VRX).